Literature DB >> 25565088

Determinants of adherence to diabetes treatment.

Amy T Larkin1, Christina Hoffman1, Adrienne Stevens2, Andrew Douglas2, Zachary Bloomgarden2.   

Abstract

BACKGROUND: Understanding and improving medication adherence is crucial in diabetes management. Adherence to a diabetes regimen can improve glucose control and limit the development of complications. The aim of the present study was to evaluate the extent to which a variety of factors influence diabetes medication adherence.
METHODS: A medication adherence survey was made available on WebMD, a medical information website for patients and/or consumers. Respondents were residents of the US, ≥18 years old, and diagnosed with either type 1 or type 2 diabetes mellitus (self-reported).
RESULTS: Behavioral adherence (self-reported doses missed per week) correlated with perceived adherence (patients' self-report of their overall impression of medication adherence, ranked 0-5; P < 0.001). Adherent patients (very few [0%-10%] issues with adherence) were more likely to report having received information from their physician. Mostly adherent patients (few [11%-26%] issues with adherence) were less likely to obtain information from their physician, but reported more medication self-titration. Somewhat non-adherent patients (some [27%-46%] adherence issues) reported more "self-consciousness factors" and hypoglycemia. Non-adherent patients (many [47%-88%] adherence issues) were more likely to report worries about medication side effects.
CONCLUSIONS: Receiving information from a healthcare provider is associated with greater diabetes medication adherence, suggesting the importance of clinicians making time to provide patient education.
© 2015 Ruijin Hospital, Shanghai Jiaotong University School of Medicine and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  diabetes; disease management; education; medication adherence; patient; 关键词:糖尿病,疾病管理,教育,用药依从性,患者

Mesh:

Substances:

Year:  2015        PMID: 25565088     DOI: 10.1111/1753-0407.12264

Source DB:  PubMed          Journal:  J Diabetes        ISSN: 1753-0407            Impact factor:   4.006


  17 in total

1.  Compliance to self-monitoring of blood glucose among patients with type 2 diabetes mellitus and its influential factors: a real-world cross-sectional study based on the Tencent TDF-I blood glucose monitoring platform.

Authors:  Zhi-De Hu; Kai-Ping Zhang; Ying Huang; Shu Zhu
Journal:  Mhealth       Date:  2017-06-27

2.  Treatment burden and perceptions of glucose-lowering therapy among people living with diabetes.

Authors:  Gerardo González-Saldivar; Juan Manuel Millan-Alanis; José Gerardo González-González; Raymundo A Sánchez-Gómez; Javier Obeso-Fernández; Rozalina G McCoy; Spyridoula Maraka; Juan P Brito; Naykky Singh Ospina; Stephie Oyervides-Fuentes; René Rodríguez-Gutiérrez
Journal:  Prim Care Diabetes       Date:  2022-04-21       Impact factor: 2.567

3.  The association of comorbid diabetes mellitus and symptoms of depression with all-cause mortality and cardiac rehospitalization in patients with heart failure.

Authors:  Geri C Reeves; Abdullah S Alhurani; Susan K Frazier; John F Watkins; Terry A Lennie; Debra K Moser
Journal:  BMJ Open Diabetes Res Care       Date:  2015-05-30

Review 4.  Cost-Effectiveness of Saxagliptin versus Acarbose as Second-Line Therapy in Type 2 Diabetes in China.

Authors:  Shuyan Gu; Yuhang Zeng; Demin Yu; Xiaoqian Hu; Hengjin Dong
Journal:  PLoS One       Date:  2016-11-22       Impact factor: 3.240

5.  Cost-Effectiveness of Dapagliflozin versus Acarbose as a Monotherapy in Type 2 Diabetes in China.

Authors:  Shuyan Gu; Yiming Mu; Suodi Zhai; Yuhang Zeng; Xuemei Zhen; Hengjin Dong
Journal:  PLoS One       Date:  2016-11-02       Impact factor: 3.240

Review 6.  Patient and physician preferences for type 2 diabetes medications: a systematic review.

Authors:  Mahdi Toroski; Abbas Kebriaeezadeh; Alireza Esteghamati; Ali Kazemi Karyani; Hadi Abbasian; Shekoufeh Nikfar
Journal:  J Diabetes Metab Disord       Date:  2019-11-11

7.  Patients' and physicians' preferences for type 2 diabetes mellitus treatments in Spain and Portugal: a discrete choice experiment.

Authors:  Carlos Morillas; Rosa Feliciano; Pablo Fernández Catalina; Carla Ponte; Marta Botella; João Rodrigues; Enric Esmatjes; Javier Lafita; Luis Lizán; Ignacio Llorente; Cristóbal Morales; Jorge Navarro-Pérez; Domingo Orozco-Beltran; Silvia Paz; Antonio Ramirez de Arellano; Cristina Cardoso; Maribel Tribaldos Causadias
Journal:  Patient Prefer Adherence       Date:  2015-10-14       Impact factor: 2.711

8.  Reported Benefits of Insulin Therapy for Better Glycemic Control in Type 2 Diabetic Patients-Is This Applicable in Saudi Patients?

Authors:  Wafaa AlSaggaf; Mohammed Asiri; Balgees Ajlan; Alaa Bin Afif; Roaa Khalil; Anas Bin Salman; Ahmed Alghamdi; Osama Bashawieh; Atheer Alamoudi; Abeer Aljahdali; Nouf Aljahdali; Hussam Patwa; Mohammed Bakhaidar; Suhad M Bahijri; Maimoona Ahmed; Khalid Al-Shali; Samia Bokhari; Amani Alhozali; Anwar Borai; Ghada Ajabnoor; Jaakko Tuomilehto
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2016-06-08

9.  Treatment choice, medication adherence and glycemic efficacy in people with type 2 diabetes: a UK clinical practice database study.

Authors:  Jason Gordon; Phil McEwan; Iskandar Idris; Marc Evans; Jorge Puelles
Journal:  BMJ Open Diabetes Res Care       Date:  2018-05-05

Review 10.  Medication adherence and persistence in patients with autoimmune rheumatic diseases: a narrative review.

Authors:  Laura-Alexandra Anghel; Andreea Maria Farcaş; Radu Nicolae Oprean
Journal:  Patient Prefer Adherence       Date:  2018-07-03       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.